Icu Medical (ICUI) Cash & Equivalents (2009 - 2026)

Icu Medical's Cash & Equivalents history runs 18 years deep, the most recent figure standing at $288.3 million for Q1 2026.

• Quarterly Cash & Equivalents changed 0.47% year-over-year to $288.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $288.3 million (changed 0.47% YoY) and the FY2025 annual result came in at $308.0 million, changed 0.2% from the prior year.
• Cash & Equivalents was $288.3 million for Q1 2026 at Icu Medical, down from $308.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $329.4 million in Q1 2022 and bottomed at $197.7 million in Q2 2023.
• A 5-year average of $268.9 million and a median of $288.3 million in 2026 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents sank 62.23% — and 2024, when it jumped 57.04%.
• Icu Medical's Cash & Equivalents stood at $208.8 million in 2022, then increased by 21.76% to $254.2 million in 2023, then gained by 21.38% to $308.6 million in 2024, then decreased by 0.2% to $308.0 million in 2025, then retreated by 6.38% to $288.3 million in 2026.
• Business Quant data shows ICUI's Cash & Equivalents at $288.3 million in Q1 2026, $308.0 million in Q4 2025, and $299.7 million in Q3 2025.